Viewing Study NCT04892693

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-01-27 @ 12:13 AM
Study NCT ID: NCT04892693
Status: RECRUITING
Last Update Posted: 2025-04-17
First Post: 2021-05-10
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant Deficiency
Sponsor: Seoul National University Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None homologous recombinant deficiency View
None biomarker study of talazoparib View
None talazoparib View
None germline View
None BRCA View